LPSN - New COVID-19 rapid testing experience uses LivePerson AI for accuracy

LivePerson ([[LPSN]] +0.7%) and COVID-19 test developer Innova Medical Group launch BELLA Health with Innova, a rapid coronavirus testing experience with AI-guided instructions for accuracy.The experience is currently being evaluated in its first large-scale at-home rapid testing clinical study in the U.S. in partnership with Citi.Innova's Rapid Antigen COVID-19 test is approved for use in the U.K. and EU, and the company is currently pursuing Emergency Use Authorization from the FDA."Testing as Americans know it today simply isn't convenient, affordable, or even accessible. Through the power of conversational AI, BELLA Health aims to become the low-cost, effective solution our communities need to enable at-home testing," says Rob LoCascio, founder and CEO of LivePerson. "BELLA Health is designed to minimize human error and support users during home testing, and the study with Citi is intended to show it can be used effectively for COVID-19 testing at scale."Press release.

For further details see:

New COVID-19 rapid testing experience uses LivePerson AI for accuracy